PeptideStack
5.2kquestions
20kanswers
220users

Would you re-test ecnoglutide after twelve weeks at 25 °C, or accept the original certificate?

Asked 18 Mar 2024Modified 2.0 years agoViewed 25k times
8

The case in front of me: ecnoglutide · twelve weeks · 25 °C.

I want to decide this in advance so that I am not deciding it under pressure later.

Assume I will follow the plan I write down, so I would like it to be a good one.

How would you structure this, and what thresholds would you set in advance?

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
ecnoglutide
ecnoglutide

A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism…

223 questions
shareeditfollowflag
OB
askedolu_babatunde6.2k1418 Mar 2024
4Do you have the chromatogram, or only the summary figure? – nils_karlberg 10 months ago
3Which wavelength was the purity integrated at? Worth adding to the question. – Dr_Bram_Verhoeven 8 months ago
add a comment

5 Answers

Accepted answer first, then by votes
97

Accepted answer

twelve weeks is 84 days, and at 25 °C the ten-degree rule of thumb makes that roughly 336 refrigerated days of equivalent exposure. 25 °C is 20 kelvin above the 5 °C middle of a 2–8 °C refrigerator. The ten-degree rule of thumb — degradation rate roughly doubling per 10 K — makes that about 4 times the refrigerated rate, which is an order-of-magnitude statement and not a shelf life. Compare that against what the certificate covers, which is the material as it left the laboratory on the date of analysis and nothing after it. 336 equivalent days is past the point where the original figure is evidence about the current vial, so the honest answer is that you no longer have a certificate for what you are holding. If you do re-test, send it for content as well as purity; the 84 days will have moved one of them further than the other.

The practical consequence is that spot-testing one vial from a new supplier is better than assuming they are all the same.

Published segregation failures show that even modern automated processes sometimes produce lots with measurable vial-to-vial variation.

Put another way, if you have reason to suspect inhomogeneity — different appearance in different vials, or a long or warm shipment — testing more vials is the diagnostic move.

Lyophilised peptide homogeneity studies show that vial-to-vial variation is usually small but occasionally large, depending on the distribution in the freeze-dryer.

If testing multiple vials, state how many you tested and why you chose those vials.

shareimprove this answerflag
RC
answered · acceptedRP_C18105k3485 May 2024
The system-suitability data is the part that tells you whether to believe the rest. – g_paskevicius 3 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
86

Thermal history during shipping is different for every vial, so a lot that experienced thermal abuse may have internal variation even if it was originally homogeneous.

The sample size determination requires choosing a confidence level and an acceptable error rate, and the smaller the error rate you want, the larger your sample must be.

Testing a vial that has been open in the lab for three months is testing aged material, not the fresh lot, and the result should be explicitly noted as a retest.

Sampling plans for pharmaceutical manufacturing are defined in ISO 2859 and ANSI Z1.4, and they are based on statistical sampling theory.

The practical summary: a lot number without a sampling statement is a lot number without meaning.

shareimprove this answerflag
HP
answeredh_pergande71k15824 Apr 2024
4Same experience here, different supplier. – dmitri_savchuk 6 months ago
5Small correction: the limit of quantitation, not the limit of detection, is the relevant one there. – bea_castellanos 9 months ago
add a comment
42

Most suppliers test one vial per lot and report the result as lot homogeneity, which is sampling one item from one lot and extrapolating wildly.

The statistical foundation here is well-established, which is why sampling plans from decades ago are still valid.

For a quantitative result like content, the acceptable range determines how many vials you need to test to establish the lot complies.

I would treat a "complies with" statement without sampling details as a claim rather than as evidence.

Assume segregation is possible, and design your sampling to catch it if it exists.

shareimprove this answerflag
CO
answeredcoldbox941k1382 Apr 2024
33

Specifically, the failure mode here is publishing a result that applies to the tested vial alone while implying it applies to the entire lot.

Stratified sampling — testing one vial from the top, one from the middle, and one from the bottom of a shipment — is cheap insurance against segregation.

Published data on lot homogeneity from manufacturers who sample multiple vials consistently find variation below the published specifications, suggesting the sampling plans work.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

edited 11 May 2024 by tobias_maartens — clarified the distinction between purity and content

shareimprove this answerflag
TM
answeredtobias_maartens171k35813 Apr 2024
32

Stated carefully, two vials tested from a lot of ten is very different from two vials tested from a lot of ten thousand, and most certificates do not state the lot size.

Acceptance Sampling by Attributes defines the number of samples you need from a lot to claim a specified quality level at a specified risk — it is in ANSI standard Z1.4.

The limitation is that you cannot know for certain without testing every vial, and you almost never can afford to do that.

In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.

edited 26 Jul 2024 by marta_okonkwo — added a caveat about sampling

shareimprove this answerflag
MO
answeredmarta_okonkwo190k2589 Jul 2024
6Adding a vote because this deserves more of them. – laminar_bench 4 months ago
5Adding for future readers: the certificate should carry the lot number, not just a batch code. – tabular_nums 3 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.